BioLife Solutions, Inc.
BLFS
$25.65
-$0.26-1.00%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 6.18% | 799.21% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 6.18% | 799.21% | |||
| Cost of Revenue | 10.21% | 169.73% | |||
| Gross Profit | 4.10% | 90.86% | |||
| SG&A Expenses | 0.21% | 143.19% | |||
| Depreciation & Amortization | 0.85% | 23,300.00% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 5.50% | 623.06% | |||
| Operating Income | 7.88% | -187.88% | |||
| Income Before Tax | -3,520.28% | -128.13% | |||
| Income Tax Expenses | 800.00% | 110.69% | |||
| Earnings from Continuing Operations | -3,435.27% | -126.76% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -3,435.27% | -103.60% | |||
| EBIT | 7.88% | -187.88% | |||
| EBITDA | 56.63% | -93.98% | |||
| EPS Basic | -3,388.42% | -103.56% | |||
| Normalized Basic EPS | 56.90% | -128.02% | |||
| EPS Diluted | -3,388.42% | -103.70% | |||
| Normalized Diluted EPS | 56.90% | -128.86% | |||
| Average Basic Shares Outstanding | 1.41% | 1.04% | |||
| Average Diluted Shares Outstanding | 1.41% | -1.87% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||